Gettysburg Cancer Center

Hillsdale, Pennsylvania 17325

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer With Low to Intermediate HER2 Expression, Myeloproliferative Neoplasms, Thrombocytosis

Studies at this site

• Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence — Completed
• A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders — Completed